Molson Coors Brewing Company (TAP)

Cheap, but the stock chart's really following the business. Beer consumption around the world, especially in NA, is down the last number of years. No matter how well it does, it can't fight that trend. Young people are moving from quantity to quality.

The older consumer is drinking less while the younger are exercising more and watching what they drink. Cannabis is another headwind, if the US legalizes it nationwide.

He's shocked by their 24% decline in the last 3 months. The street believes that all their drinks will be hurt by the popularity of the GLP-1 weight-loss drugs, but he disagrees. He would buy more shares, but it's hard to buck the GLP-1 trend.

Growth has slowed in recent months and people here and abroad have turned hard against alcohol.

This is one of the top brewers, but like all the others in the beer industry, Molson Coors is struggling. Their market is extremely mature, with declining consumption. Molson has bought some craft brewers but those companies are getting expensive. Very low multiple and generates good cash flow. They are using free cash to pay down debt. But it's difficulty to find new ways to grow. It's a tough call to say to buy because the company looks relatively cheap, well-managed but maybe not likely to grow much. They're entering into joint ventures with cannabis companies, experimenting with infused beverages. He is not sure how big the market will be for these products. It might get very crowded very quickly. For the next few years, for Molson Coors, these are small projects--tiny in the grand scheme of things.

Brewers are struggling with declining sales. Valuation is still on the rich side, mainly because of declining margins. Doesn’t have EM exposure that you’d like to see. Be cautious. Compares poorly to its peers. (Analysts’ price target is $77.43.)

Weaker volume sales in US. Core business is US and Canada. Free cash flow is about 10% free cash flow yield. Concern that beer growth is slowing. They’ve been smart and done a joint venture with a marijuana company. This is a good level to buy.

A defensive name. A company that looks to be acquired. The stock looks goods now on the pullback. Steady dividend and good yield. Maybe the fact that marihuana is being legalized affected the price of the stock and its multiples. A boring traditional business as it is

Had a terrific 2015-2016 and a “not so good” 2017. Thinks that was part of a rotation out of defensive, boring stocks into sexy technology names. This is not going to be a fast grower. It recently acquired Millers Coors, a much bigger company. Not a growth story, but more of a cost control story. There is a lot of value in this. It is worth $100 a share, and perhaps $125 in a couple of years once it pays down the debt, as well as a potential acquisition by Heineken.